Rajeev Juneja the Vice Chairman and Managing Director of Mankind Pharma has announced plans to raise Rs 10,000 crore through debt instruments. The acquisition of BSV is valued at Rs 13,630 crore and Juneja has expressed optimism about the company's future growth predicting double-digit increases in topline and EBITDA.
#mankindpharma #mankind #stockmarket
--------------------------------------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: [ Ссылка ]
Visit NDTV Profit for more news: [ Ссылка ]
Don't enter the stock market unaware. Read all Research Reports here: [ Ссылка ]
Follow NDTV Profit here
Twitter: [ Ссылка ] , [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]
